Arno Roscher

Stacks Image 3086
Having been a pathologist for over 50 years, I have been most fortunate to have witnessed the number of new developments in surgical practice grow exponentially. With the hyper-specialization of surgical practice and allied fields using current technology, especially in the area of genetics, I have felt that there is a need to have a forum, with the aim of allowing leading medical professionals to present extremely
current, state-of-the-art information in their own specialities, to the surgical community, in this new, fast-paced, information-driven age.

To that end, it has been my very great pleasure, to establish this endowed lecture series in conjunction with the International College of Surgeons, with whom I have been proud to be associated since 1968.

Honored Speakers

2016 Myocardial Stem Cells.
Ara Tilkian
Jonathan Epstein, M.D. William Wikoff Smith Professor of Cardiovascular Research, Perelman School of Medicine, Philadelphia, Pennsylvania, received his medical education from Harvard Medical School.

The Epstein laboratory is interested in molecular mechanisms of cardiovascular development and stem cell biology, and the implications of these mechanisms for understanding human disease.

Recent work focuses on the role of chromatin remodeling, histone deacetylation (HDACs) and a small homeodomain protein called Hopx that is expressed in adult stem cells.
2015 Takotsubo-Stress Cardiomyopathy.
Ara Tilkian
Ara Tilkian, M.D., FACC Director of Cardiology, Providence Holy Cross Medical Center, Mission Hills, California, Assistant Clinical Professor of Medicine at UCLA

Dr. Tilkian, a graduate of the American University of Beirut, Lebanon, received his medical education from the University of Illinois School of Medicine, and completed his internal medicine and cardiology training at Stanford University Medical Center, Stanford, California.

He has written numerous articles and two cardiology textbooks and is an editorial consultant to four specialty medical journals.
2014 The Need for a New "Gold Standard" in Cancer Diagnosis: the Role of Immunohistochemistry.
Clive R. Taylor
Clive R. Taylor, M.D. D.Phil., FRCP (Ir)., FRCPath. Chair of Pathology, University of Southern California 1984-2009; Fellow of the Royal College of Pathologists ( U.K.), Royal College of Physicians of Ireland, Member of the Royal Society of Medicine and a Diplomate of the American Board of Pathology. He has served as President of the U.S. Association of Pathology Chairs, President of the U.S. Biological Stain Commission and Chair of the FDA Advisory Panel for Diagnostic Devices. He is Editor-in-Chief of AIMM, Applied Immunihistochemestry and Molecular Morphology.
2013 Dissecting Molecular Pathways In Bladder Cancer: A Rational Approach to Prognostic Profiling and Target Discovery.
Richard J. Cote
Richard J. Cote, M.D., FRCPath, FCAP. University of Miami Miller School of Medicine, Professor and Joseph R. Coulter Jr. Chair, Department of Pathology, Chief of Pathology, Jackson Memorial Hospital, Director, Dr. John T. Macdonald Foundation Biomedical Nanotechnology Institute, Miami FL.
2012 From Double Helix to Whole-Genome Sequencing: Molecular Genetic Testing in the Age of Personalized Medicine and Surgery.
Wayne W. Grody
Wayne W. Grody M.D., PhD. Professor, Divisions of Medical Genetics and Molecular Pathology, Departments of Pathology and Laboratory Medicine, Pediatrics, and Human Genetics, UCLA School of Medicine, Los Angeles, CA. USA.
2011 Critical Bleeding and Coagulopathy Following Trauma; Implications for Blood Product and Coagulation Factor Replacement Therapy.
Ira Shulman
Ira Shulman, M.D., Professor of Pathology, Keck School of Medicine, University of Southern California, Director of Laboratories, Los Angeles County/USC Medical Center, Transfusion Services, USC Norris Cancer Hospital, Los Angeles, CA.

He is the Editor and Moderator of a transfusion medicine discussion group called the e-Network Forum that is considered the premier educational program for distance learning (and networking) in transfusion medicine.
2010 Stem Cell Therapy for the Treatment of Cardiovascular Disease.
Guilherme Silva
Guilherme Silva, M.D., Assistant Medical Director, Stem Cell Center, Texas Heart Institute at St Luke’s Episcopal Hospital, Houston, TX.

During his training at the Texas Heart Institute, Dr. Silva held the position of Chief Cardiology Fellow and Chief Interventional Cardiology Fellow and was chosen as the outstanding cardiology fellow of the 2007 graduating class.

The major focus of Dr. Silva has been in cardiovascular disease research and is one of the pioneers in the utilization of stem cells for treating heart attacks and heart failure.
2009 The Origin and Evolution of Patient Navigation: A Strategy to Reduce Health Disparities.
Harold Freeman
Harold Freeman, M.D., President and Founder of Ralph Lauren Center for Cancer Care and Prevention in New York, Founder, Harold P. Freeman Patient Navigation Institute, Senior Advisor to Director of National Cancer Institute, Director of NCI Center to Reduce Cancer Health Disparities, Surgeon Oncologist, New York, NY.

In 1979, Dr. Freeman established two free breast and cervical cancer-screening centers in Harlem in order to improve the chances of early detection. He authored the landmark report, "Cancer in the Economically Disadvantaged," which established the links between poverty and excess cancer mortality. Dr. Freeman was national president of the American Cancer Society from 1988 to 1989, is the chief architect of its Initiative on Cancer and the Poor, and was honored in 1990 by the American Cancer Society with the creation of a special award in his name.
Dr. Arno A. Roscher, M.D., is a World Governor, Vice President and US Section Representative at Large of the International College of Surgeons. He is a Clinical Professor of Pathology, Keck School of Medicine, USC (LA) Ret., and Emeritus Director of Laboratories, Henry Mayo Newhall Hospital. He is also an Emeritus member of FICS (Hon.) and FCAP and FASCP.